| Computation of Basic and Dilute Net EPS |
The following table sets forth the computation of the Company’s basic and diluted net EPS of common stock for the periods presented below (in thousands, except share and per share amount):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Quarters Ended |
|
Fiscal Years-to-Date Ended |
|
October 2, 2022 |
|
October 3, 2021 |
|
October 2, 2022 |
|
October 3, 2021 |
|
|
|
|
|
|
|
|
| Numerator: |
|
|
|
|
|
|
|
| Net loss attributable to common stockholders - basic |
$ |
(82,013) |
|
|
$ |
(10,838) |
|
|
$ |
(40,441) |
|
|
$ |
(41,306) |
|
| Increase in fair value of Private Placement Warrants |
— |
|
|
(8,460) |
|
|
(44,040) |
|
|
(8,460) |
|
| Net loss attributable to common stockholders - diluted |
$ |
(82,013) |
|
|
$ |
(19,298) |
|
|
$ |
(84,481) |
|
|
$ |
(49,766) |
|
|
|
|
|
|
|
|
|
| Denominator: |
|
|
|
|
|
|
|
| Weighted-average shares outstanding used in computing net loss per share of common stock, basic |
153,332,007 |
|
|
133,492,216 |
|
|
152,497,010 |
|
|
109,317,614 |
|
| Dilutive effect of Private Placement Warrants |
— |
|
|
1,559,912 |
|
|
1,276,261 |
|
|
536,926 |
|
| Weighted-average shares outstanding used in computing net loss per share of common stock, diluted |
153,332,007 |
|
|
135,052,128 |
|
|
153,773,271 |
|
|
109,854,540 |
|
|
|
|
|
|
|
|
|
| Net loss per share of common stock: |
|
|
|
|
|
|
|
| Basic |
$ |
(0.53) |
|
|
$ |
(0.08) |
|
|
$ |
(0.27) |
|
|
$ |
(0.38) |
|
| Diluted |
$ |
(0.53) |
|
|
$ |
(0.14) |
|
|
$ |
(0.55) |
|
|
$ |
(0.45) |
|
|
| Schedule of Anti-Dilutive Securities Excluded From Computation of Diluted Loss Per Share |
As the Company reported net loss for the periods presented above, these potentially dilutive securities were anti-dilutive and are excluded in the computation of diluted net loss per share. The following table discloses shares of the securities that were not included in the diluted EPS calculation above because they are anti-dilutive for the periods presented above.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Quarters Ended |
|
Fiscal Years-to-Date Ended |
|
October 2, 2022 |
|
October 3, 2021 |
|
October 2, 2022 |
|
October 3, 2021 |
| Stock options outstanding |
5,083,643 |
|
|
5,852,759 |
|
|
5,083,643 |
|
|
5,852,759 |
|
| Restricted stock units and performance restricted stock units outstanding |
5,933,914 |
|
|
117,611 |
|
|
5,933,914 |
|
|
117,611 |
|
| Private Placement Warrants outstanding |
6,000,000 |
|
|
— |
|
|
— |
|
|
— |
|
| Public Warrants outstanding |
— |
|
|
11,500,000 |
|
|
— |
|
|
11,500,000 |
|
| Employee stock purchase plan estimated shares |
380,847 |
|
|
— |
|
|
380,847 |
|
|
— |
|
|
|
|
|
|
|
|
|
|